Bisacodyl - Revision history

Ostermayer: Marked this version for translation

2026-01-06T21:24:52Z

Marked this version for translation

← Revisión anterior		Revisión del 21:24 6 ene 2026
Línea 2:		Línea 2:
	<translate>		<translate>

	==Administration==		==Administration== <!--T:1-->

			<!--T:2-->
	*Type: [[Special:MyLanguage/laxative\|laxative]]		*Type: [[Special:MyLanguage/laxative\|laxative]]
	*Dosage Forms: tablet, enema, suppository		*Dosage Forms: tablet, enema, suppository
Línea 11:		Línea 12:


	==Adult Dosing==		==Adult Dosing== <!--T:3-->

			<!--T:4-->
	*5-30mg PO daily		*5-30mg PO daily
	*10mg suppository daily		*10mg suppository daily


	==Pediatric Dosing==		==Pediatric Dosing== <!--T:5-->

			<!--T:6-->
	*6-11 yrs: 5mg or rectally daily		*6-11 yrs: 5mg or rectally daily

	==Special Populations==		==Special Populations== <!--T:7-->

			<!--T:8-->
	*[[Special:MyLanguage/Drug Ratings in Pregnancy\|Pregnancy Rating]]: A		*[[Special:MyLanguage/Drug Ratings in Pregnancy\|Pregnancy Rating]]: A
	*[[Special:MyLanguage/Lactation risk categories\|Lactation risk]]: infant risk cannot be ruled out		*[[Special:MyLanguage/Lactation risk categories\|Lactation risk]]: infant risk cannot be ruled out

	===Renal Dosing===		===Renal Dosing=== <!--T:9-->

			<!--T:10-->
	*Adult:		*Adult:
	*Pediatric:		*Pediatric:

	===Hepatic Dosing===		===Hepatic Dosing=== <!--T:11-->

			<!--T:12-->
	*Adult:		*Adult:
	*Pediatric:		*Pediatric:


	==Contraindications==		==Contraindications== <!--T:13-->

			<!--T:14-->
	*Allergy to class/drug		*Allergy to class/drug
	*Appendicitis		*Appendicitis
Línea 44:		Línea 51:
	*Gastroenteritis		*Gastroenteritis

	==Adverse Reactions==		==Adverse Reactions== <!--T:15-->


	===Serious===		===Serious=== <!--T:16-->

			<!--T:17-->
	*Colonic atony		*Colonic atony

	===Common===		===Common=== <!--T:18-->

			<!--T:19-->
	*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)		*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)

	==Pharmacology==		==Pharmacology== <!--T:20-->

			<!--T:21-->
	*Half-life: 8 hr		*Half-life: 8 hr
	*Metabolism: Metabolized to BHPM in the colon		*Metabolism: Metabolized to BHPM in the colon
Línea 62:		Línea 72:


	==Mechanism of Action==		==Mechanism of Action== <!--T:22-->

			<!--T:23-->
	*Stimulates peristalsis via parasympathetic reflexes		*Stimulates peristalsis via parasympathetic reflexes

	==Comments==		==Comments== <!--T:24-->


	==See Also==		==See Also== <!--T:25-->

			<!--T:26-->
	*[[Special:MyLanguage/Constipation\|Constipation]]		*[[Special:MyLanguage/Constipation\|Constipation]]

	==References==		==References== <!--T:27-->

			<!--T:28-->
	*Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]		*Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]
	*Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]		*Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]
Línea 83:		Línea 96:
	*Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. [PubMed 24345831]		*Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. [PubMed 24345831]

			<!--T:29-->
	<references/>		<references/>
	[[Category:Pharmacology]] [[Category:GI]]		[[Category:Pharmacology]] [[Category:GI]]
	</translate>		</translate>

Ostermayer: Prepared the page for translation

2026-01-04T21:44:42Z

Prepared the page for translation

← Revisión anterior		Revisión del 21:44 4 ene 2026
Línea 1:		Línea 1:
			<languages/>
			<translate>

	==Administration==		==Administration==
	*Type: [[laxative]]
			*Type: [[Special:MyLanguage/laxative\|laxative]]
	*Dosage Forms: tablet, enema, suppository		*Dosage Forms: tablet, enema, suppository
	*Dosage Strengths: tablet: 5mg; enema: 10mg/30mL; suppository: 10mg		*Dosage Strengths: tablet: 5mg; enema: 10mg/30mL; suppository: 10mg
	*Routes of Administration: PO, PR		*Routes of Administration: PO, PR
	*Common Trade Names: Dulcolax, Correctol, BisacEvac, Bisacolax, Codulax, Alophen, Feen A Mint, Fleet Stimulant Laxative, Laxit, Modane		*Common Trade Names: Dulcolax, Correctol, BisacEvac, Bisacolax, Codulax, Alophen, Feen A Mint, Fleet Stimulant Laxative, Laxit, Modane


	==Adult Dosing==		==Adult Dosing==

	*5-30mg PO daily		*5-30mg PO daily
	*10mg suppository daily		*10mg suppository daily


	==Pediatric Dosing==		==Pediatric Dosing==

	*6-11 yrs: 5mg or rectally daily		*6-11 yrs: 5mg or rectally daily

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: A
	*[[Lactation risk categories\|Lactation risk]]: infant risk cannot be ruled out		*[[Special:MyLanguage/Drug Ratings in Pregnancy\|Pregnancy Rating]]: A
			*[[Special:MyLanguage/Lactation risk categories\|Lactation risk]]: infant risk cannot be ruled out

	===Renal Dosing===		===Renal Dosing===

	*Adult:		*Adult:
	*Pediatric:		*Pediatric:

	===Hepatic Dosing===		===Hepatic Dosing===

	*Adult:		*Adult:
	*Pediatric:		*Pediatric:


	==Contraindications==		==Contraindications==

	*Allergy to class/drug		*Allergy to class/drug
	*Appendicitis		*Appendicitis
	*Bowel obstruction		*Bowel obstruction
	*Gastroenteritis		*Gastroenteritis

	==Adverse Reactions==		==Adverse Reactions==


	===Serious===		===Serious===

	*Colonic atony		*Colonic atony

	===Common===		===Common===

	*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)		*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)

	==Pharmacology==		==Pharmacology==

	*Half-life: 8 hr		*Half-life: 8 hr
	*Metabolism: Metabolized to BHPM in the colon		*Metabolism: Metabolized to BHPM in the colon
	*Excretion: Urine and bile		*Excretion: Urine and bile


	==Mechanism of Action==		==Mechanism of Action==

	*Stimulates peristalsis via parasympathetic reflexes		*Stimulates peristalsis via parasympathetic reflexes

	==Comments==		==Comments==


	==See Also==		==See Also==
	*[[Constipation]]
			*[[Special:MyLanguage/Constipation\|Constipation]]

	==References==		==References==

	*Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]		*Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]
	*Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]		*Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]
Línea 54:		Línea 85:
	<references/>		<references/>
	[[Category:Pharmacology]] [[Category:GI]]		[[Category:Pharmacology]] [[Category:GI]]
			</translate>

ClaireLewis at 21:35, 19 September 2019

2019-09-19T21:35:29Z

← Revisión anterior		Revisión del 21:35 19 sep 2019
Línea 53:		Línea 53:

	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:GI]]

Fletc151: /* References */

2019-06-10T13:29:27Z

References

← Revisión anterior		Revisión del 13:29 10 jun 2019
Línea 44:		Línea 44:
	*[[Constipation]]		*[[Constipation]]
	==References==		==References==
			*Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr. 2001;139(2):317-319. [PubMed 11487763]
			*Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. MMWR Morb Mortal Wkly Rep. 1982;31(22):290-291. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm [PubMed 6810084]
			*Christie J, Rose S. Constipation, diarrhea, hemorrhoids, and fecal incontinence. In: Pregnancy in gastrointestinal disorders. Bethesda (MD): ACG Monograph American College of Physicians; 2007. p. 4–9. Available at https://www.acg.gi.org
			*Ducodyl (bisacodyl) [prescribing information]. Troy, MI: Prime Marketing; received January 2019.
			*Friedrich C, Richter E, Trommeshauser D, et al, "Absence of Excretion of the Active Moiety of Bisacodyl and Sodium Picosulfate Into Human Breast Milk: An Open-Label, Parallel-Group, Multiple-Dose Study in Healthy Lactating Women," Drug Metab Pharmacokinet, 2011, 26(5):458-64. [PubMed 21697613]
			*"Inactive" ingredients in pharmaceutical products: update (subject review). Pediatrics.1997;99(2):268-278. [PubMed 9024461]
			*Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. [PubMed 24345831]

	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Humanguy: added half life, metabolism and excretion

2017-10-11T23:03:26Z

added half life, metabolism and excretion

← Revisión anterior		Revisión del 23:03 11 oct 2017
Línea 33:		Línea 33:
	*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)		*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)
	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 8 hr
	*Metabolism:		*Metabolism: Metabolized to BHPM in the colon
	*Excretion:		*Excretion: Urine and bile

	==Mechanism of Action==		==Mechanism of Action==

Humanguy: edited dosage forms, strengths, routes of administration, trade names

2017-10-11T23:00:44Z

edited dosage forms, strengths, routes of administration, trade names

← Revisión anterior		Revisión del 23:00 11 oct 2017
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: [[laxative]]		*Type: [[laxative]]
	*Dosage Forms:		*Dosage Forms: tablet, enema, suppository
	*Routes of Administration: ~~Oral~~, ~~suppository~~		*Dosage Strengths: tablet: 5mg; enema: 10mg/30mL; suppository: 10mg
	*Common Trade Names: ~~Ducolax~~		*Routes of Administration: PO, PR
			*Common Trade Names: Dulcolax, Correctol, BisacEvac, Bisacolax, Codulax, Alophen, Feen A Mint, Fleet Stimulant Laxative, Laxit, Modane

	==Adult Dosing==		==Adult Dosing==

Rossdonaldson1: /* Administration */

2016-08-01T04:06:51Z

Administration

← Revisión anterior		Revisión del 04:06 1 ago 2016
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: laxative		*Type: [[laxative]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: Oral, suppository		*Routes of Administration: Oral, suppository

Neil.m.young: Text replacement - "0 mg" to "0mg"

2016-07-20T08:51:19Z

Text replacement - "0 mg" to "0mg"

← Revisión anterior		Revisión del 08:51 20 jul 2016
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*5-~~30 mg~~ PO daily		*5-30mg PO daily
	*10mg suppository daily		*10mg suppository daily

Neil.m.young: Text replacement - "5 mg" to "5mg"

2016-07-18T20:35:20Z

Text replacement - "5 mg" to "5mg"

← Revisión anterior		Revisión del 20:35 18 jul 2016
Línea 10:		Línea 10:

	==Pediatric Dosing==		==Pediatric Dosing==
	*6-11 yrs: ~~5 mg~~ or rectally daily		*6-11 yrs: 5mg or rectally daily
	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: A		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: A

ClaireLewis: Created page with "==Administration== Type: laxative Dosage Forms: Routes of Administration: Oral, suppository Common Trade Names: Ducolax ==Adult Dosing== 5-30 mg PO daily 10mg supposito..."

2016-07-14T22:31:15Z

Created page with "==Administration== *Type: laxative *Dosage Forms: *Routes of Administration: Oral, suppository *Common Trade Names: Ducolax ==Adult Dosing== *5-30 mg PO daily *10mg supposito..."

Página nueva

==Administration==
*Type: laxative
*Dosage Forms:
*Routes of Administration: Oral, suppository
*Common Trade Names: Ducolax

==Adult Dosing==
*5-30 mg PO daily
*10mg suppository daily

==Pediatric Dosing==
*6-11 yrs: 5 mg or rectally daily
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: A
*[[Lactation risk categories|Lactation risk]]: infant risk cannot be ruled out
===Renal Dosing===
*Adult:
*Pediatric:
===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug
*Appendicitis
*Bowel obstruction
*Gastroenteritis
==Adverse Reactions==
===Serious===
*Colonic atony
===Common===
*Abdominal discomfort/colic, diarrhea, proctitis (with suppository use)
==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==
*Stimulates peristalsis via parasympathetic reflexes
==Comments==

==See Also==
*[[Constipation]]
==References==
<references/>
[[Category:Pharmacology]]